Pharmafile Logo
Pharmafocus logo
Advanced Search

Wilson’s disease

Showing 1 posts of 1 posts found.

Alexion $855m portfolio boost after Wilson Therapeutics buyout

April 11, 2018
Research and Development, Sales and Marketing Alexion, Wilson's Therapeutics, Wilson's disease, biotech, drugs, pharma, pharmaceutical

Alexion Pharmaceuticals is badly in need of alternative revenue streams to Soliris, its mega-blockbuster that could start to face competition …

News
The Gateway to Local Adoption Series

Latest content

NanoSomiX and Beckman Coulter Diagnostics collaborate on blood tests for neurodegenerative diseases

July 30, 2026

EMA selects TrialAssure anonymisation platform for clinical trial documents

July 30, 2026

Researchers develop new antifungal compounds with improved safety profile

July 29, 2026

Lonza and Engitix partner to develop next-generation antibody-drug conjugates

July 28, 2026

Simris Group appoints Tiffany J Vora as Strategic Advisor

July 28, 2026